Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Updated efficacy data reported for L-DOS-47 in NSCLC

Sep. 9, 2015

Cationically modified dextran heparin antidotes show promise in vivo

Sep. 9, 2015

Novel BET inhibitors designed for treating brain cancer

Sep. 8, 2015

Novel SLC22A5 gene mutation linked to ADHD

Sep. 8, 2015

VCP-746, a cardioprotective adenosine receptor agonist

Sep. 8, 2015

Caenorhabditis elegans used to model weight gain resulting from antipsychotic use

Sep. 8, 2015

FORUM Pharmaceuticals describes PDE9A inhibitors that may improve cognition

Sep. 7, 2015

Cellsight Technologies PET tracer [18F]F-AraG first-in-human results are positive

Sep. 7, 2015

Dose-response effects described for encenicline in schizophrenia

Sep. 7, 2015

Amgen reports new BACE1 inhibitors for the treatment of AD

Sep. 4, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...